These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28502495)

  • 1. Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry.
    Chiou KR; Charng MJ
    J Clin Lipidol; 2017; 11(2):386-393.e6. PubMed ID: 28502495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-based resequencing for mutations causing familial hypercholesterolemia.
    Chiou KR; Charng MJ; Chang HM
    Atherosclerosis; 2011 Jun; 216(2):383-9. PubMed ID: 21376320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex MassARRAY spectrometry (iPLEX) produces a fast and economical test for 56 familial hypercholesterolaemia-causing mutations.
    Wright WT; Heggarty SV; Young IS; Nicholls DP; Whittall R; Humphries SE; Graham CA
    Clin Genet; 2008 Nov; 74(5):463-8. PubMed ID: 18700895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China.
    Chiou KR; Charng MJ
    Gene; 2012 Apr; 498(1):100-6. PubMed ID: 22353362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
    Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia.
    Chiou KR; Charng MJ
    Am J Cardiol; 2010 Jun; 105(12):1752-8. PubMed ID: 20538126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
    Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia.
    Tejedor D; Castillo S; Mozas P; Jiménez E; López M; Tejedor MT; Artieda M; Alonso R; Mata P; Simón L; Martínez A; Pocoví M;
    Clin Chem; 2005 Jul; 51(7):1137-44. PubMed ID: 15890894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic testing for familial hypercholesterolemia in the Netherlands: a stepwise screening strategy enhances the mutation detection rate.
    Lombardi MP; Redeker EJ; van Gent DH; Smeele KL; Weerdesteijn R; Mannens MM
    Genet Test; 2006; 10(2):77-84. PubMed ID: 16792510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia.
    Thiart R; Varret M; Lintott CJ; Scott RS; Loubser O; du Plessis L; de Villiers JN; Boileau C; Kotze MJ
    Mol Cell Probes; 2000 Oct; 14(5):299-304. PubMed ID: 11040093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia.
    Vaca G; Vàzquez A; Magaña MT; Ramìrez ML; Dàvalos IP; Martìnez E; Marìn B; Carrillo G
    Atherosclerosis; 2011 Oct; 218(2):391-6. PubMed ID: 21722902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene.
    Lind S; Rystedt E; Eriksson M; Wiklund O; Angelin B; Eggertsen G
    Atherosclerosis; 2002 Aug; 163(2):399-407. PubMed ID: 12052488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of familial hypercholesterolaemia in Norway.
    Leren TP; Tonstad S; Gundersen KE; Bakken KS; Rødningen OK; Sundvold H; Ose L; Berg K
    J Intern Med; 1997 Mar; 241(3):185-94. PubMed ID: 9104431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
    García-Otín AL; Cofán M; Junyent M; Recalde D; Cenarro A; Pocoví M; Ros E; Civeira F
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3667-73. PubMed ID: 17566095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate.
    Graham CA; McIlhatton BP; Kirk CW; Beattie ED; Lyttle K; Hart P; Neely RD; Young IS; Nicholls DP
    Atherosclerosis; 2005 Oct; 182(2):331-40. PubMed ID: 16159606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.